Clinical Trial Update: The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer

View source ↗

Summary

This document describes a clinical trial updating the use of the novel radiotracer 99mTc-NC100692 in individuals at high risk for or with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 99mTc-NC100692 (NC100692)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Breast Cancer, Tumor Angiogenesis | Status: UNKNOWN